# Damien Sanderlin, MD, Houston, TX – FDA Inspections

Source: https://www.keypedia.com/companies/damien-sanderlin-md/ee882a7a-e0f5-4507-a51a-8796cab9d12f

> Inspection records and compliance data for Damien Sanderlin, MD in Houston, Texas. 2 FDA inspections on record (2 OAI), last inspected July 18, 2012.

---

## Details

- Name: Damien Sanderlin, MD
- FEI Number: 3009417634
- Address Line 1: Lone Star Clinical Research, 8240 Antoine Dr Ste 107
- City: Houston
- State: Texas
- Zip Code: 77088
- Country Name: United States
- Address: Lone Star Clinical Research, 8240 Antoine Dr Ste 107, Houston, Texas 77088, United States
- Country: United States

## Related Documents

- [EIR - Damien Sanderlin, MD - 2012-07-18](https://www.keypedia.com/records/eir/damien-sanderlin-md/7da50374-195a-495d-81bf-f0c01290608a) — source: FDA, date: July 18, 2012
- [FDA Inspection 790026 - Damien Sanderlin, MD - 2012-07-18](https://www.keypedia.com/records/fda_inspections/damien-sanderlin-md/c0ef4d71-a730-4bf1-b9f9-ba6dc73fb184) — classification: Official Action Indicated (OAI), source: FDA, date: July 18, 2012
- [EIR - Damien Sanderlin, MD - 2012-03-29](https://www.keypedia.com/records/eir/damien-sanderlin-md/4e1fec54-90a8-479c-8e16-1820b80c6bf7) — source: FDA, date: March 29, 2012
- [483 - Damien Sanderlin, MD - 2012-03-29](https://www.keypedia.com/records/483/damien-sanderlin-md/08ccd4e9-1c38-4111-b0e7-e518f24d7e0c) — source: FDA, date: March 29, 2012
- [FDA Inspection 775234 - Damien Sanderlin, MD - 2012-03-29](https://www.keypedia.com/records/fda_inspections/damien-sanderlin-md/b6ee764f-53bb-4b09-935f-ca1c0faf0102) — classification: Official Action Indicated (OAI), source: FDA, date: March 29, 2012

## Related Companies

- [Douglas R Schumacher MD](https://www.keypedia.com/companies/douglas-r-schumacher-md/3b5fce34-88ce-43b7-b257-7eee5deee7ed)
- [PharmaLegacy Research LLC](https://www.keypedia.com/companies/pharmalegacy-research-llc/bdd63a11-ccc9-46b9-892e-e7f7548ef0a9)
- [PATH](https://www.keypedia.com/companies/path/6bc709e7-8d81-4236-ac15-d52c82bd00a5)
- [Emergent Manufacturing Operations Baltimore LLC.](https://www.keypedia.com/companies/emergent-manufacturing-operations-baltimore-llc/4dd5f6a4-4f17-4262-8b3e-2a4133eccc8c)
- [Xo Biologix](https://www.keypedia.com/companies/xo-biologix/733af757-6b13-401a-8abd-d8b5628ffd76)
- [Frontier Biologics LLC](https://www.keypedia.com/companies/frontier-biologics-llc/825af140-e32e-421a-a99e-c1567b18c7ce)
- [Mother Frances Hospital IRB](https://www.keypedia.com/companies/mother-frances-hospital-irb/5068618d-52b8-40ac-b357-61524c081190)
- [Celltex Therapeutics Corporation](https://www.keypedia.com/companies/celltex-therapeutics-corporation/74a0e909-b729-43a2-a75b-5878dda5f179)
- [INCELL Corporation LLC](https://www.keypedia.com/companies/incell-corporation-llc/d4d60997-99ce-45b7-be66-c76ff6e80ec5)
- [Mark R. Newton, M.D.](https://www.keypedia.com/companies/mark-r-newton-md/4d423034-05af-4f20-9051-6a67a4610ffb)

## Related Officers

- [Acting Program Division Director ](https://www.keypedia.com/people/charles-d-brown/8b817b44-437e-476c-b2b2-1c4c6e7e7b54)
- [investigator](https://www.keypedia.com/people/damien-sanderlin/1c62d03c-85cc-46b8-8aa0-72dac54794d7)
- [company_representative](https://www.keypedia.com/people/monica-brown/2e1f507f-dc0a-40ed-8602-2ca1d1b04ed2)
